₹220
(Inclusive of all Taxes)
₹33.0 Cashback (15%)
Prescription drugWhats That
Secure Payment
India's Most Trusted Pharmacy
Genuine Products
Also Explore
रचना :
रेपेग्लिनाइड-2एमजी
निर्माता/विपणक :
एवरिट हेल्थकेयर
सेवन का प्रकार :
मौखिक
वापसी नीति :
वापसी योग्य नहीं
Drug-Drug Interactions
Critical
Critical
Drug-Drug Interactions
Login/Sign Up
Critical
How does the drug interact with Repanew 1 Tablet:
Coadministration of Repanew 1 Tablet with Gatifloxacin may sometimes affect blood glucose levels. Both low blood glucose and, less frequently, high blood glucose have been reported.
How to manage the interaction:
Although there is a possible interaction, Repanew 1 Tablet can be taken with Gatifloxacin if prescribed by the doctor. However, consult the doctor if you experience unusual symptoms. Do not stop using any medications without first talking to your doctor.
Coadministration of Repanew 1 Tablet with Gatifloxacin may sometimes affect blood glucose levels. Both low blood glucose and, less frequently, high blood glucose have been reported.
How to manage the interaction:
Although there is a possible interaction, Repanew 1 Tablet can be taken with Gatifloxacin if prescribed by the doctor. However, consult the doctor if you experience unusual symptoms. Do not stop using any medications without first talking to your doctor.
Critical
How does the drug interact with Repanew 1 Tablet:
When Repanew 1 Tablet is taken with Gemfibrozil, the level of Repanew 1 Tablet in the blood can go up. This can increase the risk or severity of side effects.
How to manage the interaction:
Taking Repanew 1 Tablet with Gemfibrozil can possibly result in an interaction, it can be taken if a doctor has advised it. However, if you experience sudden dizziness, lightheadedness, fainting, shortness of breath, chest pain or tightness, rapid heartbeat, or memory loss, contact a doctor immediately. Do not discontinue any medications without consulting a doctor.
When Repanew 1 Tablet is taken with Gemfibrozil, the level of Repanew 1 Tablet in the blood can go up. This can increase the risk or severity of side effects.
How to manage the interaction:
Taking Repanew 1 Tablet with Gemfibrozil can possibly result in an interaction, it can be taken if a doctor has advised it. However, if you experience sudden dizziness, lightheadedness, fainting, shortness of breath, chest pain or tightness, rapid heartbeat, or memory loss, contact a doctor immediately. Do not discontinue any medications without consulting a doctor.
Severe
How does the drug interact with Repanew 1 Tablet:
Coadministration of Repanew 1 Tablet with gemifloxacin can affect blood glucose levels. Both high blood glucose (hyperglycemia) and, to a lesser extent, low blood glucose (hypoglycemia).
How to manage the interaction:
Although taking Repanew 1 Tablet together with Gemifloxacin can possibly result in an interaction, they can be taken together if prescribed by your doctor. However, contact a doctor immediately if you experience any symptoms of hypoglycemia or hyperglycemia, such as headache, dizziness, drowsiness, anxiety, weakness, tremors, nausea, hunger, sweating, and palpitation, increased thrust, increased hunger, and increased urination. Do not discontinue any medicine without consulting a doctor.
Coadministration of Repanew 1 Tablet with gemifloxacin can affect blood glucose levels. Both high blood glucose (hyperglycemia) and, to a lesser extent, low blood glucose (hypoglycemia).
How to manage the interaction:
Although taking Repanew 1 Tablet together with Gemifloxacin can possibly result in an interaction, they can be taken together if prescribed by your doctor. However, contact a doctor immediately if you experience any symptoms of hypoglycemia or hyperglycemia, such as headache, dizziness, drowsiness, anxiety, weakness, tremors, nausea, hunger, sweating, and palpitation, increased thrust, increased hunger, and increased urination. Do not discontinue any medicine without consulting a doctor.
How does the drug interact with Repanew 1 Tablet:
Coadministration of Repanew 1 Tablet with nalidixic acid can affect blood glucose levels. Both high blood glucose (hyperglycemia) and, to a lesser extent, low blood glucose (hypoglycemia).
How to manage the interaction:
Although taking Repanew 1 Tablet together with Nalidixic acid can possibly result in an interaction, they can be taken together if prescribed by your doctor. Consult the doctor if you experience symptoms such as nervousness, confusion, headache, dizziness, drowsiness, tremors, nausea, hunger, weakness, perspiration, palpitation, rapid heartbeat, increased urination, increased thirst, and increased hunger. Maintaining blood glucose levels is advised. Do not stop using any medications without talking to a doctor.
Coadministration of Repanew 1 Tablet with nalidixic acid can affect blood glucose levels. Both high blood glucose (hyperglycemia) and, to a lesser extent, low blood glucose (hypoglycemia).
How to manage the interaction:
Although taking Repanew 1 Tablet together with Nalidixic acid can possibly result in an interaction, they can be taken together if prescribed by your doctor. Consult the doctor if you experience symptoms such as nervousness, confusion, headache, dizziness, drowsiness, tremors, nausea, hunger, weakness, perspiration, palpitation, rapid heartbeat, increased urination, increased thirst, and increased hunger. Maintaining blood glucose levels is advised. Do not stop using any medications without talking to a doctor.
RepaglinideEluxadoline
Severe
How does the drug interact with Repanew 1 Tablet:
Coadministration of Repanew 1 Tablet with eluxadoline may increase the blood levels Repanew 1 Tablet.
How to manage the interaction:
Although taking Repanew 1 Tablet together with Eluxadoline can possibly result in an interaction, they can be taken together if prescribed by your doctor. However, contact a doctor immediately if you experience any unusual symptoms Do not discontinue any medicine without consulting a doctor.
Coadministration of Repanew 1 Tablet with eluxadoline may increase the blood levels Repanew 1 Tablet.
How to manage the interaction:
Although taking Repanew 1 Tablet together with Eluxadoline can possibly result in an interaction, they can be taken together if prescribed by your doctor. However, contact a doctor immediately if you experience any unusual symptoms Do not discontinue any medicine without consulting a doctor.
Severe
How does the drug interact with Repanew 1 Tablet:
Co-administration of Ofloxacin and Repanew 1 Tablet can sometimes have an effect on blood glucose levels.
How to manage the interaction:
Although combining Ofloxacin and Repanew 1 Tablet can possibly lead to an interaction, they can be taken on doctor's advice. If you experience any symptoms of hypoglycemia (headache, dizziness, sleepiness, nervousness, confusion, shaking, nausea, hunger, weakness, sweat, palpitation, and rapid heartbeat) or hyperglycemia (increased thirst, hunger, and urination), notify your doctor. Keep an eye on your blood glucose levels. Do not discontinue any medications without first consulting a doctor.
Co-administration of Ofloxacin and Repanew 1 Tablet can sometimes have an effect on blood glucose levels.
How to manage the interaction:
Although combining Ofloxacin and Repanew 1 Tablet can possibly lead to an interaction, they can be taken on doctor's advice. If you experience any symptoms of hypoglycemia (headache, dizziness, sleepiness, nervousness, confusion, shaking, nausea, hunger, weakness, sweat, palpitation, and rapid heartbeat) or hyperglycemia (increased thirst, hunger, and urination), notify your doctor. Keep an eye on your blood glucose levels. Do not discontinue any medications without first consulting a doctor.
RepaglinideCinoxacin
Severe
How does the drug interact with Repanew 1 Tablet:
Taking Repanew 1 Tablet with cinoxacin can affect blood glucose levels. Both high blood glucose (hyperglycemia) and, to a lesser extent, low blood glucose (hypoglycemia).
How to manage the interaction:
Although taking Repanew 1 Tablet together with Cinoxacin can possibly result in an interaction, they can be taken together if prescribed by your doctor. However, contact a doctor immediately if you experience any symptoms of hypoglycemia, such as headache, dizziness, drowsiness, anxiety, weakness, tremors, nausea, hunger, sweating, and fast heartbeat. Do not discontinue any medicine without consulting a doctor.
Taking Repanew 1 Tablet with cinoxacin can affect blood glucose levels. Both high blood glucose (hyperglycemia) and, to a lesser extent, low blood glucose (hypoglycemia).
How to manage the interaction:
Although taking Repanew 1 Tablet together with Cinoxacin can possibly result in an interaction, they can be taken together if prescribed by your doctor. However, contact a doctor immediately if you experience any symptoms of hypoglycemia, such as headache, dizziness, drowsiness, anxiety, weakness, tremors, nausea, hunger, sweating, and fast heartbeat. Do not discontinue any medicine without consulting a doctor.
Severe
How does the drug interact with Repanew 1 Tablet:
Coadministration of Repanew 1 Tablet and ciclosporin can increase the blood levels and effects of Repanew 1 Tablet.
How to manage the interaction:
Although taking Repanew 1 Tablet together with ciclosporin can possibly result in an interaction, they can be taken together if prescribed by your doctor. However, contact a doctor immediately if you experience headache, dizziness, drowsiness, anxiety, weakness, shaking, nausea, hunger, sweating, and palpitation. Do not discontinue any medicine without consulting a doctor.
Coadministration of Repanew 1 Tablet and ciclosporin can increase the blood levels and effects of Repanew 1 Tablet.
How to manage the interaction:
Although taking Repanew 1 Tablet together with ciclosporin can possibly result in an interaction, they can be taken together if prescribed by your doctor. However, contact a doctor immediately if you experience headache, dizziness, drowsiness, anxiety, weakness, shaking, nausea, hunger, sweating, and palpitation. Do not discontinue any medicine without consulting a doctor.
Severe
How does the drug interact with Repanew 1 Tablet:
Taking Repanew 1 Tablet with ciprofloxacin can effect blood sugar levels, both hyperglycemia (high blood sugar) and, less frequently, hypoglycemia (low blood sugar).
How to manage the interaction:
Although taking ciprofloxacin and Repanew 1 Tablet together can possibly result in an interaction, it can be taken if your doctor has prescribed it. However, tell your doctor if you experience hypoglycemia, hyperglycemia, or a decline in blood glucose control. Hypoglycemia can cause headaches, dizziness, sleepiness, anxiety, disorientation, tremors, nausea, hunger, weakness, sweat, palpitations, and a rapid heartbeat. Increased hunger, thirst, and urine are all possible signs of hyperglycemia. Consult your doctor if you experience any of the above symptoms.
Taking Repanew 1 Tablet with ciprofloxacin can effect blood sugar levels, both hyperglycemia (high blood sugar) and, less frequently, hypoglycemia (low blood sugar).
How to manage the interaction:
Although taking ciprofloxacin and Repanew 1 Tablet together can possibly result in an interaction, it can be taken if your doctor has prescribed it. However, tell your doctor if you experience hypoglycemia, hyperglycemia, or a decline in blood glucose control. Hypoglycemia can cause headaches, dizziness, sleepiness, anxiety, disorientation, tremors, nausea, hunger, weakness, sweat, palpitations, and a rapid heartbeat. Increased hunger, thirst, and urine are all possible signs of hyperglycemia. Consult your doctor if you experience any of the above symptoms.
RepaglinideGrepafloxacin
Severe
How does the drug interact with Repanew 1 Tablet:
Coadministration of Repanew 1 Tablet with grepafloxacin can affect blood glucose levels. Both high blood glucose (hyperglycemia) and, to a lesser extent, low blood glucose (hypoglycemia).
How to manage the interaction:
Although taking Repanew 1 Tablet together with Grepafloxacin can possibly result in an interaction, they can be taken together if prescribed by your doctor. However, contact a doctor immediately if you experience any symptoms of hypoglycemia or hyperglycemia, such as headache, dizziness, drowsiness, anxiety, weakness, tremors, nausea, hunger, sweating, and palpitation, increased thrust, increased hunger, and increased urination. Do not discontinue any medicine without consulting a doctor.
Coadministration of Repanew 1 Tablet with grepafloxacin can affect blood glucose levels. Both high blood glucose (hyperglycemia) and, to a lesser extent, low blood glucose (hypoglycemia).
How to manage the interaction:
Although taking Repanew 1 Tablet together with Grepafloxacin can possibly result in an interaction, they can be taken together if prescribed by your doctor. However, contact a doctor immediately if you experience any symptoms of hypoglycemia or hyperglycemia, such as headache, dizziness, drowsiness, anxiety, weakness, tremors, nausea, hunger, sweating, and palpitation, increased thrust, increased hunger, and increased urination. Do not discontinue any medicine without consulting a doctor.
Drug-Food Interactions
REPAGLINIDE-1MGGrapefruit and Grapefruit Juice
Moderate
Drug-Food Interactions
Login/Sign Up
REPAGLINIDE-1MGGrapefruit and Grapefruit Juice
Moderate
Common Foods to Avoid:
Grapefruit Juice, Grapefruit
How to manage the interaction:
Taking Repanew 1 Tablet and grapefruit or grapefruit juice together can increase the blood levels and effects of Repanew 1 Tablet. Avoid the consumption of Grapefruit or grapefruit juice.
Grapefruit Juice, Grapefruit
How to manage the interaction:
Taking Repanew 1 Tablet and grapefruit or grapefruit juice together can increase the blood levels and effects of Repanew 1 Tablet. Avoid the consumption of Grapefruit or grapefruit juice.
Product Substitutes
शराब
असुरक्षित
अप्रिय दुष्प्रभावों से बचने के लिए आपको Repanew 1 Tablet 10's के साथ शराब का सेवन न करने की सलाह दी जाती है।
गर्भावस्था
सावधानी
Repanew 1 Tablet 10's गर्भावस्था श्रेणी C की दवा है। चूँकि गर्भवती महिलाओं में Repanew 1 Tablet 10's के उपयोग के बारे में डेटा सीमित है, इसलिए गर्भावस्था में Repanew 1 Tablet 10's का उपयोग प्रतिबंधित है। यदि आप गर्भवती हैं तो इस दवा को लेने से पहले अपने डॉक्टर से परामर्श करने की अत्यधिक अनुशंसा की जाती है।
स्तनपान
सावधानी
यह ज्ञात नहीं है कि Repanew 1 Tablet 10's मानव दूध में उत्सर्जित होता है या नहीं। स्तनपान के दौरान Repanew 1 Tablet 10's का उपयोग करने से पहले कृपया डॉक्टर से सलाह लें।
ड्राइविंग
सावधानी
यदि आपके रक्त शर्करा का स्तर बहुत अधिक या बहुत कम है तो आपकी ड्राइविंग प्रभावित हो सकती है। यदि आपको अत्यधिक निम्न या उच्च रक्त शर्करा के कारण धुंधली दृष्टि, च Dizziness Dizziness का भी अनुभव हो तो वाहन न चलाएं या मशीनरी न चलाएं।
जिगर
सावधानी
Repanew 1 Tablet 10's सावधानी के साथ लेना है, खासकर यदि आपको लीवर के रोगों/स्थितियों का इतिहास रहा है। आपके डॉक्टर द्वारा खुराक को समायोजित करना पड़ सकता है। हालांकि, गंभीर जिगर की बीमारी के लिए Repanew 1 Tablet 10's की सिफारिश नहीं की जाती है।
गुर्दा
सावधानी
Repanew 1 Tablet 10's सावधानी के साथ लेना है, खासकर यदि आपको गुर्दे की बीमारियों/स्थितियों का इतिहास रहा है। आपके डॉक्टर द्वारा खुराक को समायोजित करना पड़ सकता है। हालांकि, गंभीर गुर्दे की बीमारी के लिए Repanew 1 Tablet 10's की सिफारिश नहीं की जाती है।
बच्चे
असुरक्षित
बच्चों में Repanew 1 Tablet 10's की सुरक्षा और प्रभावकारिता स्थापित नहीं की गई है। बच्चों में Repanew 1 Tablet 10's की सिफारिश नहीं की जाती है।
Have a query?
Disclaimer
While we strive to provide complete, accurate, and expert-reviewed content on our 'Platform', we make no warranties or representations and disclaim all responsibility and liability for the completeness, accuracy, or reliability of the aforementioned content. The content on our platform is for informative purposes only, and may not cover all clinical/non-clinical aspects. Reliance on any information and subsequent action or inaction is solely at the user's risk, and we do not assume any responsibility for the same. The content on the Platform should not be considered or used as a substitute for professional and qualified medical advice. Please consult your doctor for any query pertaining to medicines, tests and/or diseases, as we support, and do not replace the doctor-patient relationship.
Author Details
